A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer
Status:
Unknown status
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
Investigators would like to assess the efficacy and safety of tegafur-uracil in patients with
stage II MSI-L or MSS colon cancer under metronomic setting for one year.